Jason Haas, Chief Financial Officer at Syros Pharmaceuticals, Inc. (SYRS), sold 137,803 shares at $0.21 ($29K) on 2024-11-18, disclosed to the SEC on 2024-11-20.
Open-market sale of $29k SYRS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ODTX | BUY | 2026-05-11 | $20K | — | Filing → |
| SYRS | BUY | 2024-09-12 | $292K | — | Filing → |